The Recall Desk
HighFDA (Devices)·Z-2296-2026·Announced 2026-06-10

[pending] Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT (Part 2 of 2)) used with the Medrad¿ Ava

Pending LLM rewrite. Source: FDA_DEVICE Z-2296-2026.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

Supplier changes resulted in a fit issue with the Contrast Flow Control Valve (CFCV) interface on the Avanta Injector System. Multiple customer reports indicate that the stopcock cannot be reliably engaged with the CFCV snap interface. In instances where engagement is achieved through applied force, the connection is unstable, and the stopcock may disengage before or during contrast injection, leading to procedure interruption.

The recalled product

Product
Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT (Part 2 of 2)) used with the Medrad¿ Avanta Injection System; Catalog number: AVA 500 MPAT (Part 2 of 2); Affected material numbers: 87629007, 60729458, 86566648;
Manufacturer
Bayer Medical Care, Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (17)

  • Catalog number: AVA 500 MPAT (Part 2 of 2) Affected material numbers: 87629007
  • 60729458
  • 86566648
  • Affected batch numbers: 251702
  • 252302
  • 252502
  • 252602
  • 252702
  • 252802
  • 253304
  • 253702
  • 253704
  • 253804
  • 254202
  • 254304
  • 254704
  • 254802

Distribution

Distributed nationwide across the United States.